Physicians and scientists from Longevity Medical Institute® have published new peer-reviewed research examining the safety of allogeneic mesenchymal stem cell therapies across a broad range of human ...

Mitochondria are essential for cell survival, repair, and adaptation. Not only do they generate most of the energy needed ...

The ORR was 70% in patients treated with remestemcel-L, with 30% having a complete response and 41% having a partial response. The Food and Drug Administration (FDA) has approved Ryoncil ® ...

Compared with an injection of saline placebo, a single intra-articular injection of autologous adipose-derived mesenchymal stromal cells showed no significant improvement in pain or function scores in ...

The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...

The stroma to tumor ratio potentially identifies higher risk bladder cancer tumors and might help guide immunotherapy. Bladder tumors with higher stromal content may have a more immunosuppressive ...

Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to quietly gain dominance with age. Reprogrammed stromal cells and interferon ...

LOS CABOS, BAJA CALIFORNIA SUR, Mexico, March 17, 2026 /PRNewswire/ -- Physicians and scientists from Longevity Medical Institute(R) have published new peer-reviewed research examining the safety of ...

Mitochondrial transplantation is an emerging technique aimed at restoring cellular energy production in diseases marked by mitochondrial dysfunction. However, how transplanted mitochondria interact ...